Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Innovent Biologics Inc ADR (OTC : IVBIY) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
Innovent is a China-based biotechnology company that is developing drugs for a wide array of diseases, especially oncology therapeutics. Founded in 2011, it listed on the Hong Kong Stock Exchange in 2018. Its core asset is Tyvyt, a PD-1 inhibitor. It also has a portfolio of biosimilars and other fast follower drugs. Innovent has been adept global business development, having out-licensed Tyvyt to Eli Lilly and in-licensed innovative drugs from several partners.
Quote
| Last: | $40.295 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $40.295 |
| Close: | $40.295 |
| High: | $40.295 |
| Low: | $40.295 |
| Volume: | 303 |
| Last Trade Date Time: | 06/02/2026 01:08:33 pm |
Stock Data
| Market Cap: | $16,125,411,279 |
|---|---|
| Float: | 405,670,724 |
| Insiders Ownership: | N/A |
| Institutions: | |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Country: | CN |
| City: |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about Innovent Biologics Inc ADR (OTC: IVBIY).
